Summary & Overview
HCPCS G9585: Opioid Risk Screening Not Completed
HCPCS Level II code G9585 documents that a patient receiving opioid therapy was not evaluated for opioid misuse risk with a brief validated screening tool or was not interviewed at least once during therapy. This code captures gaps in opioid risk assessment and monitoring that are central to efforts to reduce opioid-related harm. Nationally, consistent use of validated screening instruments and documented follow-up interviews are considered elements of safer opioid prescribing and coordinated care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of what G9585 represents, how it maps to clinical processes for opioid therapy management, and why accurate documentation matters for quality measurement and care coordination. The publication outlines expected service settings and the types of benchmarks and policy issues typically associated with this code, including performance measurement around opioid prescribing and monitoring.
The report provides clinical context for opioid risk screening, discusses documentation implications for ambulatory and behavioral health settings, and highlights the types of analyses readers can expect (benchmark comparisons, payer coverage patterns, and policy update summaries). Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9585 indicates that a patient was not evaluated for risk of misuse of opiates using a brief validated instrument (e.g., opioid risk tool, soapp-r) or was not interviewed at least once during opioid therapy. This represents a documentation or care-process gap related to opioid risk assessment and monitoring.
Service Type: Behavioral health / medication safety assessment (opioid risk screening and counseling context)
Typical Site of Service: Outpatient clinic, primary care office, behavioral health setting, or any ambulatory care setting where opioid therapy is managed
Clinical & Coding Specifications
Clinical Context
A primary care clinician evaluates a 48-year-old patient with chronic low back pain who has been on long-term opioid therapy. During a routine follow-up visit, the clinician is expected to assess opioid misuse risk using a brief validated instrument (for example, the Opioid Risk Tool or SOAPP-R) and to conduct at least one interview during the course of opioid therapy. In this scenario documentation indicates that no validated risk instrument was administered and no interview specifically addressing opioid misuse risk was performed during the reporting period. The typical workflow includes intake vitals and medication reconciliation, review of prescription drug monitoring program (PDMP) data, administration of a brief validated risk screen when indicated, counseling and documentation of risk assessment, and periodic follow-up interviews while opioids are prescribed. For this billing code the service type is non-covered/negative quality reporting of a missed clinical requirement related to opioid risk assessment. The typical site of service is outpatient primary care clinics, pain management clinics, and behavioral health integrated clinics where opioid prescribing and monitoring occur. The typical patient scenario reflects ongoing opioid therapy without documented risk screening or at least one provider interview focused on misuse risk.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work beyond usual service is documented, e.g., extended counseling related to opioids during the visit. |